D68.312 vs D68.5
D68.312 (Antiphospholipid antibody with hemorrhagic disorder) compared with D68.5 (Primary thrombophilia), from the official CMS tabular data. Do not report these codes together: the official tabular list marks them Excludes1.
Can these codes be reported together?
No — do not report together. D68.5 carries an Excludes1 note covering D68.312: “systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)”
Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
Side by side
| D68.312Antiphospholipid antibody with hemorrhagic disorder | D68.5Primary thrombophilia | |
|---|---|---|
| Billing status | Billable | Non-billable header |
| Classification | D50-D89 — Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) | D50-D89 — Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) |
| Definition | Antiphospholipid antibody with hemorrhagic disorder is a billable ICD-10-CM diagnosis code (D68.312). | Primary thrombophilia is a non-billable ICD-10-CM category code (D68.5). |
| Includes | Lupus anticoagulant (LAC) with hemorrhagic disorder Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder | Primary hypercoagulable states |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources